Cite
HARVARD Citation
Belda, F. et al. (2022). Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine. Vaccine. 40 (22), pp. 2993-2998. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Belda, F. et al. (2022). Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine. Vaccine. 40 (22), pp. 2993-2998. [Online].